Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.
about
Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescenceAcetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stressFundamentals of cancer metabolismMetabolic, autophagic, and mitophagic activities in cancer initiation and progressionMechanisms of ferroptosisTargeting of Mutant p53 and the Cellular Redox Balance by APR-246 as a Strategy for Efficient Cancer TherapyIs cancer a metabolic disease?Tumor suppressor p53 and its gain-of-function mutants in cancerRole of the p53 tumor suppressor in metabolismTumor suppressor p53 and its mutants in cancer metabolismP53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapySmoking, p53 mutation, and lung cancerAnother fork in the road--life or death decisions by the tumour suppressor p53The role of tumor suppressor p53 in the antioxidant defense and metabolismSmall molecule compounds targeting the p53 pathway: are we finally making progress?The rebel angel: mutant p53 as the driving oncogene in breast cancer.Caught in the cross fire: p53 in inflammation.An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse modelFunction of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative diseaseThe role of the p53 tumor suppressor in metabolism and diabetesp53 Acetylation: Regulation and ConsequencesTwo 4N cell-cycle arrests contribute to cisplatin-resistanceResveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent mannerINMAP overexpression inhibits cell proliferation, induces genomic instability and functions through p53/p21 pathwaysTIGAR is required for efficient intestinal regeneration and tumorigenesisAn extra copy of p53 suppresses development of spontaneous Kras-driven but not radiation-induced cancerThe p53-Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humansChemical metabolic inhibitors for the treatment of blood-borne cancersROS function in redox signaling and oxidative stressMutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.Misfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.Non-cell-autonomous tumor suppression by p53.Enterocyte-specific inactivation of SIRT1 reduces tumor load in the APC(+/min) mouse model.Cancer: A piece of the p53 puzzle.Ferroptosis: A missing puzzle piece in the p53 blueprint?Interplay between Mdm2 and HIPK2 in the DNA damage response.Targeting tumor suppressor networks for cancer therapeutics.The traditional Chinese medical compound Rocaglamide protects nonmalignant primary cells from DNA damage-induced toxicity by inhibition of p53 expressionDiscovery of Mieap-regulated mitochondrial quality control as a new function of tumor suppressor p53Chemosensitivity and p53; new tricks by an old dog
P2860
Q24310386-5FCB7FF2-B5B3-4C22-BBFA-1151616103C7Q24339569-E01F453C-DC01-4119-B95F-3366FD5EEAC6Q26744062-F79A3139-A398-4EE5-BE1E-ED9936B54435Q26745503-C0DD72F1-2869-4A59-BA9E-4651EE1713AFQ26751418-5FE4E2E4-6634-4204-843E-29C153D31071Q26766341-10767B53-3866-4EF6-8347-6138C105AB20Q26852241-871272A9-0DF5-4068-BCDF-5B3934DB7BD6Q27000754-235BF11F-3B1B-46EE-B0EC-2E30669EEA45Q27000971-8925A70F-06D7-4EB9-A5DF-45AF45502814Q27010683-A1BA6A39-40AF-497F-8921-AA5540E56FD9Q27011547-34D46572-81F9-4E3F-9949-BD13CF280FA6Q27014977-009256DF-3375-42F6-A9C6-579E7F0AAB39Q27026310-6447DCFD-4D39-4984-B216-BC72727BED80Q27027604-C0FF499B-03B6-4676-BFB7-E5A40017CD04Q27027835-533A72D6-1CB0-48DD-975B-AA867012B554Q27686765-6C138B49-205B-43F3-8D3C-7C8E05DCA0D0Q27692076-F3BED9B4-A975-4B64-9480-02846E1BFDDEQ27853369-59AECE92-5017-4024-9B05-8B4156951F24Q28068499-7E5BDB9C-9323-4FA6-9159-FF74EBBB6166Q28079903-5A18F8E3-8B07-4D08-A27D-0DC071B04ADFQ28085076-E974CBC5-85BA-4172-B1F1-CEFB644AD5ABQ28485896-D670E9D0-5CCE-4602-BD37-545CBF22D8AAQ28535352-41319967-FFF3-4137-8EE1-B3393B0048A8Q28543171-2DB6E156-2FB9-4805-A718-0DE22EA93846Q28585472-B3BCBD00-A107-4C3B-8A3F-43A9E1BC7BBCQ28596032-3AED40D1-3ABF-41BE-9FAD-E6228D5DA243Q28601272-33AD9F0D-24F3-4322-A997-78F542D29A89Q28822335-582DA3D3-CFF0-4136-AD0A-8487F0966DAFQ29615229-2A8FD0FF-A662-4535-984D-6063F4B1B206Q30354662-B76444B4-EC2A-450E-A14E-692876DE8C1CQ30374671-D35D9984-AD2B-4FE3-B20C-5928AE616F45Q30541182-2A029621-8C85-4C06-997F-D5CAD101FE6EQ31120854-A0117619-A55E-4902-A427-CDC8D4DAB907Q33360347-86DC98C2-91DA-4670-997F-E73E3E78A5E8Q33363357-8B04CF86-B6AD-4857-88C3-9ED165EE2619Q33656086-45F229D1-8DE9-438D-A140-8C34F078082AQ33657519-D8C073C9-B24D-4393-A3F4-9A7F01562AD5Q33695077-5DFA282A-AACB-4D9A-8177-3CB806C53E59Q33738750-31DBAB00-37DF-4F96-AD1F-66B4D3C0FE23Q33739325-91C3B3A4-6D5A-4CAC-94A2-E99A1268BB68
P2860
Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Tumor suppression in the absen ...... st, apoptosis, and senescence.
@en
Tumor suppression in the absen ...... st, apoptosis, and senescence.
@nl
type
label
Tumor suppression in the absen ...... st, apoptosis, and senescence.
@en
Tumor suppression in the absen ...... st, apoptosis, and senescence.
@nl
prefLabel
Tumor suppression in the absen ...... st, apoptosis, and senescence.
@en
Tumor suppression in the absen ...... st, apoptosis, and senescence.
@nl
P2093
P2860
P1433
P1476
Tumor suppression in the absen ...... st, apoptosis, and senescence.
@en
P2093
Minjia Tan
Richard Baer
Thomas Ludwig
Tongyuan Li
Yingming Zhao
P2860
P304
P356
10.1016/J.CELL.2012.04.026
P407
P577
2012-06-01T00:00:00Z